Invention Grant
- Patent Title: Anti-PD-L1 antibodies
-
Application No.: US15328232Application Date: 2015-08-05
-
Publication No.: US10435470B2Publication Date: 2019-10-08
- Inventor: Jiping Zha , Ziyong Sun , Junzhuan Qiu
- Applicant: CB Therapeutics, Inc.
- Applicant Address: US CA Santa Clara
- Assignee: CB Therapeutics, Inc.
- Current Assignee: CB Therapeutics, Inc.
- Current Assignee Address: US CA Santa Clara
- Agency: Cooley LLP
- Priority: WOPCT/CN2014/083715 20140805
- International Application: PCT/US2015/043723 WO 20150805
- International Announcement: WO2016/022630 WO 20160211
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K47/68
Abstract:
The present disclosure relates to antibodies and antigen-binding fragments thereof that bind to PD-L1, and to methods of using such antibodies and antigen-binding fragments. For example, the present invention provides humanized anti-PD-L1 antibodies and methods of use thereof.
Public/Granted literature
- US20170204184A1 ANTI-PD-L1 ANTIBODIES Public/Granted day:2017-07-20
Information query
